Skip to content

A Study Comparing Two Ways of Giving Dexamethasone with a Local Anaesthetic Injection to Reduce Pain After forearm Surgery

perineural or intravenous dexamethasone as an adjunct to ropivacaine for prevention of rebound pain in ultrasound guided supraclavicular block a randomized placebo control trial - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/102167
Enrollment
90
Registered
2026-01-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S529- Unspecified fracture of forearm

Interventions

Intervention1: USG guided brachial plexus block: The effectivity of prevention of rebound pain will be assessed with perineurally administered dexamethasone 8mg with 20cc of 0.5 % ropivacaine under us

Sponsors

MB Government Hospital Rnt Medical College Udaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: all consenting adults age 18-80 years ASA 1 AND 2 category of either gender undergoing open reduction and internal fixation of fracture forearm boe under brachial plexus block

Exclusion criteria

Exclusion criteria: patients already on steroid therapy patients with diabetes mellitus patients allergic to study drugs

Design outcomes

Primary

MeasureTime frame
the proportion of patients experiencing rebound pain defined as a score of more than or equal to 7 on visual assessment scale in the first 48 hoursTimepoint: the proportion of patients experiencing rebound pain defined as a score of more than or equal to 7 on visual assessment scale in the first 48 hours

Secondary

MeasureTime frame
the time of occurrence of first episode of rebound painTimepoint: The Visual Analogue Scale Score of 0,1,2,4,8,24 ,36,48 hours postoperatively will he assessed;The Visual Analogue Scale Score of 0,1,2,4,8,24 ,36,48 hours postoperatively will he assessedTimepoint: 0,1,2,4,8,24 ,36,48 hours postoperatively will he assessed;the cumulative tramadol consumption in the first 24 hoursTimepoint: First 24 hours

Countries

India

Contacts

Public ContactVikram Bedi

RNT Medical College

Vbedimd@gmail.com09829025373

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026